KCNA3 and Huntington disease: Various potassium channels are recognized as potential therapeutic targets in the treatment of MS, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease (HD), epilepsy, stroke, brain tumors, brain/spinal cord ischemia, pain and schizophrenia, and migraine [15,16,19].